Immunic to Participate in Industry, Scientific and Investor Conferences in November
Press Releases
October 29, 2024

Immunic to Participate in Industry, Scientific and Investor Conferences in November

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

bradford

The Bradford Era

Local & Social